Brain atrophy accelerates cognitive decline in cerebral small vessel disease The LADIS study

Neurology

Volumn 78, Issue 22, 2012, Pages 1785-1792

  Jokinen, H ^a   Lipsanen, J ^a   Schmidt, R ^a   Fazekas, F ^a   Gouw, A A ^b   Van Der Flier, W M ^b   Barkhof, F ^b   Madureira, S ^c   Verdelho, A ^c   Ferro, J M ^c   Wallin, A ^d   Pantoni, L ^e   Inzitari, D ^f   Erkinjuntti, T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Centro de Estudos Egas Moniz   (Portugal)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX ATROPHY; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; STROKE; TEMPORAL LOBE; WHITE MATTER LESION;

EID: 84863629974     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182583070     Document Type: Article

References (40)

1. Bastos-Leite AJ, van der Flier WM, van Straaten EC, Staekenborg SS, Scheltens P, Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007; 38:3182-3185. (Pubitemid 350175734)
2. Staekenborg SS, van Straaten EC, van der Flier WM, Lane R, Barkhof F, Scheltens P. Small vessel versus large vessel vascular dementia: Risk factors and MRI findings. J Neurol 2008;255:1644-1651.
3. Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000;59:23-30. (Pubitemid 30479402)
4. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
5. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral smallvessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-2041. (Pubitemid 41253271)
6. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam scan study. Stroke 2008;39:2712-2719.
7. Jokinen H, Gouw AA, Madureira S, et al. Incident lacunes influence cognitive decline: The LADIS study. Neurology 2011;76:1872-1878.
8. Godin O, Maillard P, Crivello F, et al. Association of white-matter lesions with brain atrophy markers: The three-city Dijon MRI study. Cerebrovasc Dis 2009;28: 177-184.
9. Kril JJ, Patel S, Harding AJ, Halliday GM. Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry 2002;72:747-751. (Pubitemid 34557018)
10. Fein G, Di Sclafani V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626-1635.
11. Mungas D, Jagust WJ, Reed BR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 2001;57:2229-2235. (Pubitemid 34016456)
12. Jokinen H, Kalska H, Ylikoski R, et al. Medial temporal lobe atrophy and memory deficits in elderly stroke patients. Eur J Neurol 2004;11:825-832. (Pubitemid 39665059)
13. Mungas D, Harvey D, Reed BR, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005;65:565-571. (Pubitemid 41170716)
14. Jokinen H, Kalska H, Mantyla R, et al. White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry 2005;76: 1229-1233. (Pubitemid 41208373)
15. Mok VC, Liu T, Lam WW, et al. Neuroimaging predictors of cognitive impairment in confluent white matter lesion: Volumetric analyses of 99 brain regions. Dement Geriatr Cogn Disord 2008;25:67-73. (Pubitemid 350308389)
16. van der Flier WM, van Straaten EC, Barkhof F, et al. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: The LADIS study. J Neurol Neurosurg Psychiatry 2005;76:1497-1500. (Pubitemid 41531692)
17. Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline: TheAustrian stroke prevention study. Ann Neurol 2005;58: 610-616. (Pubitemid 41377225)
18. Nitkunan A, Lanfranconi S, Charlton RA, Barrick TR, Markus HS. Brain atrophy and cerebral small vessel disease: A prospective follow-up study. Stroke 2011;42:133-138.
19. Pantoni L, Basile AM, Pracucci G, et al. Impact of agerelated cerebral white matter changes on the transition to disability: The LADIS study: Rationale, design and methodology. Neuroepidemiology 2005;24:51-62. (Pubitemid 39664108)
20. Inzitari D, Pracucci G, Poggesi A, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: Three year follow-up of LADIS (Leukoaraiosis and disability) study cohort. BMJ 2009; 339:b2477.
21. van Straaten EC, Fazekas F, Rostrup E, et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: The LADIS study. Stroke 2006;37: 836-840. (Pubitemid 43731918)
22. Schmidt R, Ropele S, Ferro J, et al. Diffusion-weighted imaging and cognition in the Leukoariosis and disability in the elderly study. Stroke 2010;41:e402-e408.
23. Ryberg C, Rostrup E, Sjostrand K, et al. White matter changes contribute to corpus callosum atrophy in the elderly: The LADIS study. AJNR Am J Neuroradiol 2008; 29:1498-1504.
24. Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability. J Neurol 1995;242:557-560.
25. Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and disability study. Stroke 2008;39:1414-1420.
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
27. Ferris SH. General measures of cognition. Int Psychogeriatr 2003;15(suppl 1):215-217. (Pubitemid 37175193)
28. MacLeod CM. Half a century of research on the Stroop effect: An integrative review. Psychol Bull 1991;109:163-203.
29. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
30. Madureira S, Verdelho A, Ferro J, et al. Development of a neuropsychological battery for the Leukoaraiosis and disability in the elderly study (LADIS): Experience and baseline data. Neuroepidemiology 2006;27:101-116. (Pubitemid 44387445)
31. Cardenas VA, Chao LL, Studholme C, et al. Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol Aging 2011;32:572-580.
32. Seo SW, Ahn J, Yoon U, et al. Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type. J Neuroimaging 2010;20:37-45.
33. Mok V, Wong KK, Xiong Y, et al. Cortical and frontal atrophy are associated with cognitive impairment in agerelated confluent white-matter lesion. J Neurol Neurosurg Psychiatry 2011;82:52-57.
34. Bonelli RM, Cummings JL. Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci 2007;9:141-151. (Pubitemid 47075462)
35. Muller M, Appelman AP, van der Graaf Y, Vincken KL, Mali WP, Geerlings MI. Brain atrophy and cognition: Interaction with cerebrovascular pathology? Neurobiol Aging 2011;32:885-893.
36. Appelman AP, Vincken KL, van der Graaf Y, et al. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: The SMART-MR study. Cerebrovasc Dis 2010;29:28-35.
37. Godin O, Tzourio C, Rouaud O, et al. Joint effect of white matter lesions and hippocampal volumes on severity of cognitive decline: The 3C-Dijon MRI study. J Alzheimers Dis 2010;20:453-463.
38. Wahlund LO, Julin P, Johansson SE, Scheltens P. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: A comparative study. J Neurol Neurosurg Psychiatry 2000;69:630-635.
39. Bresciani L, Rossi R, Testa C, et al. Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: Comparison with volumetry. Aging Clin Exp Res 2005;17:8-13. (Pubitemid 43073053)
40. Jokinen H, Kalska H, Ylikoski R, et al. Longitudinal cognitive decline in subcortical ischemic vascular disease: The LADIS study. Cerebrovasc Dis 2009;27:384-391.